Clinical Trials Logo

Recurrent GBM clinical trials

View clinical trials related to Recurrent GBM.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT04763031 Terminated - Glioblastoma Clinical Trials

Recurrent GBM With Maximal Neurosurgical Removal and Treatment With IORT

Start date: March 5, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the safety and efficacy of the Xoft Axxent eBx System when used for single-fraction IORT for recurrent Glioblastoma. IORT using the Xoft Axxent eBx System is no worse than (non-inferior) GliaSite radiation therapy when used as stand-alone radiation treatment immediately following maximal safe neurosurgical resection in patients with recurrent glioblastoma multiforme (GBM).

NCT ID: NCT04681677 Terminated - Glioblastoma Clinical Trials

Recurrent GBM Treated With Neurosurgical Resection and IORT Using the Xoft Axxent eBx System and Bevacizumab

IORT
Start date: November 2, 2021
Phase: Phase 2
Study type: Interventional

The purpose of this trial is to assess the overall survival of patients treated with the Xoft Axxent eBx System and post-radiation adjuvant Bevacizumab for single-fraction IORT following maximal neurosurgical resection of recurrent glioblastoma. A historical comparison will be made to the results of the EBRT + Bevacizumab arm of RTOG 1205.